These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism. Chiba Y, Fujishiro H, Ota K, Kasanuki K, Arai H, Hirayasu Y, Sato K, Iseki E. Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913 [Abstract] [Full Text] [Related]
4. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography. Imai M, Tanaka M, Sakata M, Wagatsuma K, Tago T, Toyohara J, Sengoku R, Nishina Y, Kanemaru K, Ishibashi K, Murayama S, Ishii K. J Alzheimers Dis; 2020 Mar; 73(1):197-207. PubMed ID: 31771066 [Abstract] [Full Text] [Related]
5. Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies. Kang S, Jeon S, Lee YG, Ye BS. Alzheimers Res Ther; 2024 Apr 23; 16(1):89. PubMed ID: 38654300 [Abstract] [Full Text] [Related]
6. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA. Alzheimers Dement; 2008 Jan 23; 4(1 Suppl 1):S67-76. PubMed ID: 18632004 [Abstract] [Full Text] [Related]
7. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study. Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, Hüll M, Meyer PT, Frings L. J Neuroimaging; 2015 Jan 23; 25(2):281-288. PubMed ID: 24593796 [Abstract] [Full Text] [Related]
8. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Exp Neurol; 2005 Feb 23; 191 Suppl 1():S95-S103. PubMed ID: 15629765 [Abstract] [Full Text] [Related]
9. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, Bradshaw J, Merory J, Woodward M, Hopwood M, Rowe CC. J Nucl Med; 2009 Oct 23; 50(10):1638-45. PubMed ID: 19759102 [Abstract] [Full Text] [Related]
15. Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition. Ishii K, Hosokawa C, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Hosono M, Yamazoe Y, Murakami T. Ann Nucl Med; 2015 Jan 23; 29(1):78-83. PubMed ID: 25270712 [Abstract] [Full Text] [Related]
16. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies. Gupta HV, Beach TG, Mehta SH, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Liebsack C, Dugger BN, Serrano GE, Sue LI, Siderowf A, Pontecorvo MJ, Mintun MA, Joshi AD, Adler CH. J Alzheimers Dis; 2021 Jan 23; 80(4):1603-1612. PubMed ID: 33720879 [Abstract] [Full Text] [Related]
17. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. Shimada H, Hirano S, Sinotoh H, Ota T, Tanaka N, Sato K, Yamada M, Fukushi K, Irie T, Zhang MR, Higuchi M, Kuwabara S, Suhara T. Int J Geriatr Psychiatry; 2015 Nov 23; 30(11):1105-13. PubMed ID: 26280153 [Abstract] [Full Text] [Related]
18. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy. Shimada H, Shinotoh H, Hirano S, Miyoshi M, Sato K, Tanaka N, Ota T, Fukushi K, Irie T, Ito H, Higuchi M, Kuwabara S, Suhara T. Mov Disord; 2013 Feb 23; 28(2):169-75. PubMed ID: 23225334 [Abstract] [Full Text] [Related]
19. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN. BMC Neurol; 2014 Apr 09; 14():79. PubMed ID: 24716655 [Abstract] [Full Text] [Related]
20. Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model. Gjerum L, Frederiksen KS, Henriksen OM, Law I, Bruun M, Simonsen AH, Mecocci P, Baroni M, Dottorini ME, Koikkalainen J, Lötjönen J, Hasselbalch SG. Neuroimage Clin; 2020 Apr 09; 27():102267. PubMed ID: 32417727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]